背景:虚拟现实为用户提供了一个通过完全沉浸式平台进行学习的独特机会,可能有益于研究生医学教育:研究的主要目的是评估虚拟现实技术在培训妇产科住院医师插入产后球囊处理产后出血方面的可行性:这是一项多中心随机对照试验,从2023年7月3日至7月6日,来自爱尔兰都柏林国家妇产医院(The National Maternity Hospital)和罗通达(The Rotunda)两家三级围产中心的产科住院医师(n=40)参与了这项试验。参与者被随机分配到干预组(21 人)和对照组(19 人)。所有参与者都填写了一份研究前调查表,对产后出血处理的知识、经验、信心水平、对虚拟现实的体验以及对在医学教育中使用虚拟现实的看法进行评估。干预组接受了虚拟现实沉浸式教程,而对照组没有接受任何教学。决定不向对照组提供任何教学,是为了反映我们医院的现状,即在产房值夜班或周末值班之前,没有关于插入产后球囊的定期正式教学。在这一场景中使用 VR 为住院医师提供了一个进行无障碍模拟训练的新机会。然后,两组人员都接受了在模型骨盆中插入产后子宫球囊的测试。根据制造商的指导原则,对住院医师进行计时,并对插入技术进行客观标记。在模型上插入后,参与者完成了一项调查,包括对虚拟现实技术的知识、信心水平、满意度、副作用和益处的评估。主要结果是对住院医师在骨盆模型中插入球囊技术的结构化客观评估。次要结果是完成任务所需的时间、知识和信心水平以及虚拟现实技术的任何副作用。我们对分类数据进行了描述性统计,如频率和百分比。我们使用配对 t 检验来比较干预前后多选问卷和信心水平的平均得分。统计显著性的定义是 p 值为 结果:与对照组相比,干预组在学习体验后的客观技术评估中得分明显更高(9.29/10 vs 7.26/10,PC结论:虚拟现实技术有利于住院医师教授产后球囊插入的技术、所需时间和信心水平。
期刊介绍:
The American Journal of Obstetrics and Gynecology (AJOG) is a highly esteemed publication with two companion titles. One of these is the American Journal of Obstetrics and Gynecology Maternal-Fetal Medicine (AJOG MFM), which is dedicated to the latest research in the field of maternal-fetal medicine, specifically concerning high-risk pregnancies. The journal encompasses a wide range of topics, including:
Maternal Complications: It addresses significant studies that have the potential to change clinical practice regarding complications faced by pregnant women.
Fetal Complications: The journal covers prenatal diagnosis, ultrasound, and genetic issues related to the fetus, providing insights into the management and care of fetal health.
Prenatal Care: It discusses the best practices in prenatal care to ensure the health and well-being of both the mother and the unborn child.
Intrapartum Care: It provides guidance on the care provided during the childbirth process, which is critical for the safety of both mother and baby.
Postpartum Issues: The journal also tackles issues that arise after childbirth, focusing on the postpartum period and its implications for maternal health. AJOG MFM serves as a reliable forum for peer-reviewed research, with a preference for randomized trials and meta-analyses. The goal is to equip researchers and clinicians with the most current information and evidence-based strategies to effectively manage high-risk pregnancies and to provide the best possible care for mothers and their unborn children.